CA2286893A1 - Polypeptides d'helicobacter de 76 kda, 32 kda et 50 kda et molecules de polynucleotides correspondantes - Google Patents

Polypeptides d'helicobacter de 76 kda, 32 kda et 50 kda et molecules de polynucleotides correspondantes Download PDF

Info

Publication number
CA2286893A1
CA2286893A1 CA002286893A CA2286893A CA2286893A1 CA 2286893 A1 CA2286893 A1 CA 2286893A1 CA 002286893 A CA002286893 A CA 002286893A CA 2286893 A CA2286893 A CA 2286893A CA 2286893 A1 CA2286893 A1 CA 2286893A1
Authority
CA
Canada
Prior art keywords
asn
ala
seq
leu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002286893A
Other languages
English (en)
Inventor
Harold Kleanthous
Ling Lissolo
Jean-Francois Tomb
Charles Miller
Amal Al-Garawi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERIEUX ORAVAX
Human Genome Sciences Inc
Original Assignee
Merieux Oravax
Human Genome Sciences, Inc.
Harold Kleanthous
Ling Lissolo
Jean-Francois Tomb
Charles Miller
Amal Al-Garawi
Oravax Merieux Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/834,666 external-priority patent/US20020044949A1/en
Priority claimed from US08/831,310 external-priority patent/US20020026035A1/en
Application filed by Merieux Oravax, Human Genome Sciences, Inc., Harold Kleanthous, Ling Lissolo, Jean-Francois Tomb, Charles Miller, Amal Al-Garawi, Oravax Merieux Co. filed Critical Merieux Oravax
Publication of CA2286893A1 publication Critical patent/CA2286893A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002286893A 1997-04-01 1998-03-31 Polypeptides d'helicobacter de 76 kda, 32 kda et 50 kda et molecules de polynucleotides correspondantes Abandoned CA2286893A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/831,310 1997-04-01
US08/834,666 1997-04-01
US08/834,666 US20020044949A1 (en) 1997-04-01 1997-04-01 76 kda helicobacter polypeptides and corresponding polynucleotide molecules
US08/831,310 US20020026035A1 (en) 1997-04-01 1997-04-01 Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules
PCT/US1998/006421 WO1998043479A1 (fr) 1997-04-01 1998-03-31 POLYPEPTIDES D'HELICOBACTER DE 76 kDa, 32 kDa ET 50 kDa ET MOLECULES DE POLYNUCLEOTIDES CORRESPONDANTES

Publications (1)

Publication Number Publication Date
CA2286893A1 true CA2286893A1 (fr) 1998-10-08

Family

ID=27125431

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286893A Abandoned CA2286893A1 (fr) 1997-04-01 1998-03-31 Polypeptides d'helicobacter de 76 kda, 32 kda et 50 kda et molecules de polynucleotides correspondantes

Country Status (5)

Country Link
EP (1) EP0980204A4 (fr)
JP (1) JP2001523954A (fr)
AU (1) AU750792B2 (fr)
CA (1) CA2286893A1 (fr)
WO (1) WO1998043479A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000614A2 (fr) * 1998-06-26 2000-01-06 American Cyanamid Company NOUVEAUX ANTIGENES D'$i(HELIOBACTER PYLORI)
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
WO2002066502A1 (fr) * 2001-02-21 2002-08-29 Boren Thomas Adhesine de liaison de l'acide sialique d'helicobacter pylori, saba et gene de saba
ES2294051T3 (es) * 2002-01-15 2008-04-01 Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. Vacunacion oral con mimotopos desnudos de antigenos tumorales.
IL162857A0 (en) * 2002-01-15 2005-11-20 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Oral vaccination
JP5250812B2 (ja) * 2006-04-27 2013-07-31 国立大学法人富山大学 ヘリコバクター・ピロリ菌由来の新規抗原、抗原組成物およびピロリ菌抗体の検出方法。

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー,ソーマス・ユリウス 胃腸障害治療のための改良された方法
US5258178A (en) * 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US5258729A (en) * 1992-08-06 1993-11-02 Eaton Corporation Case circuit breaker having improved attachment means for accessory devices and accessory devices therefor
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
US5563039A (en) * 1995-03-31 1996-10-08 Tularik, Inc. TNF receptor-associated intracellular signaling proteins and methods of use
WO1996040893A1 (fr) * 1995-06-07 1996-12-19 Astra Aktiebolag Sequences d'acide nucleique et d'acides amines concernant helicobacter pylori, utilisees a des fins diagnostiques et therapeutiques
DE19535321A1 (de) * 1995-09-22 1997-03-27 Max Planck Gesellschaft Neues Adhäsin aus Helicobacter pylori
FR2739623B1 (fr) * 1995-10-04 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire p76 d'helicobacter pylori

Also Published As

Publication number Publication date
AU6875798A (en) 1998-10-22
EP0980204A4 (fr) 2005-06-15
AU750792B2 (en) 2002-07-25
JP2001523954A (ja) 2001-11-27
EP0980204A1 (fr) 2000-02-23
WO1998043479A1 (fr) 1998-10-08

Similar Documents

Publication Publication Date Title
JP4271952B2 (ja) ワクチンおよび診断に有用なHelicobacterpyloriタンパク質
US7700755B2 (en) Helicobacter pylori CAI antigen
CA2286306A1 (fr) Identification de polynucleotides codant de nouveaux polypeptides helicobacter dans le genome helicobacter
CA2373021A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
CA2321106A1 (fr) Antigenes du streptocoque du groupe b
WO2002018595A9 (fr) Polypeptides de moraxella et fragments d'adn correspondants et utilisations
JP2000125889A (ja) アクチノバチルス・プレウロニウモニアからのタンパク質
CA2353107A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation
US7192725B2 (en) Flagellin gene, flaC of Campylobacter
CZ297698A3 (cs) Sekvence nukleové kyseliny a aminokyselinové sekvence vztahující se k Helicobacter pylori a její vakcinační kompozice
CA2286893A1 (fr) Polypeptides d'helicobacter de 76 kda, 32 kda et 50 kda et molecules de polynucleotides correspondantes
US20030158396A1 (en) Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
AU735391B2 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
US20020115078A1 (en) Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US20030124141A1 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
US20030023066A1 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
US20020160456A1 (en) Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US20020026035A1 (en) Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules
US20020044949A1 (en) 76 kda helicobacter polypeptides and corresponding polynucleotide molecules
US7141244B1 (en) Helicobacter pylori proteins useful for vaccines and diagnostics
KR100437955B1 (ko) 헬리코박터필로리(Helicobacterpylori)로부터의부착유전자및그에의해암호화된폴리펩티드
US20030069404A1 (en) Helicobacter antigens and corresponding DNA fragments
CA2414125A1 (fr) Operon virb de bartonella henselae et proteines codees par cet operon
EP1535928B1 (fr) Vaccin comprenant Omp85 protéines de Neisseria gonorhoeae et Neisseria meningitidis
JP2001503637A (ja) ヘリコバクターポリペプチドおよび対応するポリヌクレオチド分子

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued